Home - Boston Life Sciences Times

LATEST ARTICLES

Public Health

Brighton Marine Launches $100,000 Basic-Needs Initiative to Support Boston Veterans

Life Sciences Times - November 13, 20250

Biotech

Agilent Awards UC Davis Researcher for Pioneering Work in Peptide Therapeutics

Life Sciences Times - November 12, 20250

People on the Move

Drive Health Appoints Dr. Matthew Crowson as Chief Medical Officer

Life Sciences Times - November 12, 20250

Medtech

Hologic Expands Genius Digital Diagnostics System With CE Marking for Digital Pathology

Life Sciences Times - November 12, 20250

Technology

AI for Every Practice: eClinicalWorks Survey Reveals Expanding Role of Artificial Intelligence in Healthcare

Life Sciences Times - November 12, 20250

Venture Capital

Quality Means Business Secures $2 Million Seed Funding to Launch QualiVerse Regulatory Intelligence Platform

Life Sciences Times - November 12, 20250

Biotech

PepGen Receives U.S. Patent for Proprietary PGN-EDODM1 Molecule

Life Sciences Times - November 12, 20250

Venture Capital

Atomic Launches Innovative Model to Help MedTech Startups Transition from Vision to Venture

Life Sciences Times - November 12, 20250

Biotech

Neochromosome and GlobalBio Introduce Pre-Transformed Antibody Libraries on Switchable Yeast Platform

Life Sciences Times - November 12, 20250

Biotech

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

Life Sciences Times - November 12, 20250

1...757677...831 Page 76 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

POPULAR CATEGORY

ABOUT US

FOLLOW US